On November 6, 2023, ORTHOPEDIATRICS CORP ($NASDAQ:KIDS) reported their FY2023 Q3 earnings, with total revenue of USD 40.0 million, a 14.4% increase from the same quarter in 2022. Net income for the quarter was USD -4.6 million, compared to USD 18.5 million the previous year.
Analysis – Orthopediatrics Corp Intrinsic Stock Value
GoodWhale has conducted an analysis of the fundamentals of ORTHOPEDIATRICS CORP. Our proprietary Valuation Line has indicated that the intrinsic value of ORTHOPEDIATRICS CORP’s shares is around $59.0. Currently, the ORTHOPEDIATRICS CORP stock is trading at $27.4, which represents a 53.6% undervaluation. This pricing discrepancy provides a great opportunity for investors to get a good return on their investments. More…
Star Chart Analysis
About the Company
Ownership (Institutional/ Fund Holdings)
Below shows the total revenue, net income and net margin for Orthopediatrics Corp. More…
Income Statement Reports (Yearly/ Quarterly/ LTM)
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Orthopediatrics Corp. More…
Cash Flow Statement (Yearly/ Quarterly/ LTM)
Cash Flow Supplement
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Orthopediatrics Corp. More…
Balance Sheet (Yearly/ Quarterly)
Balance Sheet Supplement
||Book Value Per Share
Key Ratios Snapshot
Some of the financial key ratios for Orthopediatrics Corp are shown below. More…
Income Statement Ratios
Balance Sheet Ratios
Cash Flow Ratios
Other Supplementary Items
|3Y Rev Growth
||3Y Operating Profit Growth
The medical device industry is fiercely competitive, with OrthoPediatrics Corp competing against Acotec Scientific Holdings Ltd, ECGI Holdings Inc, and CVR Medical Corp. All four companies are striving to develop the best products and services to meet the needs of their patients. While all four companies offer different products and services, they all share a commitment to providing the highest quality care possible.
– Acotec Scientific Holdings Ltd ($SEHK:06669)
Acotec Scientific Holdings Ltd is a company that focuses on the research and development of medical technologies. They have a market capitalization of 2.53 billion as of 2022 and a return on equity of -3.65%. The company’s products are used in the treatment of various diseases and conditions, including cancer, cardiovascular disease, and neurological disorders.
ECGI Holdings Inc is a holding company that operates in the real estate industry. The company has a market capitalization of 1.7 million as of 2022 and a return on equity of 400.03%. ECGI Holdings Inc is engaged in the business of owning, developing, and managing real estate properties. The company’s portfolio of properties includes residential, commercial, and industrial properties.
ORTHOPEDIATRICS CORP reported its Q3 financial results for FY2023, showing total revenue of USD 40.0 million, with a year-on-year growth of 14.4%.
However, their net income for the same quarter declined significantly to USD -4.6 million compared to USD 18.5 million in the same period last year. Investors should be wary of this earnings report and assess the company’s financial position before making any decisions. It is also necessary to analyze their past performance in order to make an informed decision. Short-term investors may want to stay away from ORTHOPEDIATRICS CORP at this moment, while long-term investors should research the company further before investing.